SEARCH

SEARCH BY CITATION

References

  • Abbas AK, Xia W, Tranberg M, Wigstrom H, Weber SG, Sandberg M. 2008. S-sulfo-cysteine is an endogenous amino acid in neonatal rat brain but an unlikely mediator of cysteine neurotoxicity. Neurochem Res 33:301307.
  • Abumrad NN. 1984. Molybdenum—is it an essential trace metal? Bull N Y Acad Med 60:163171.
  • Appignani BA, Kaye EM, Wolpert SM. 1996. CT and MR appearance of the brain in two children with molybdenum cofactor deficiency. AJNR Am J Neuroradiol 17:317320.
  • Arenas M, Fairbanks LD, Vijayakumar K, Carr L, Escuredo E, Marinaki AM. 2009. An unusual genetic variant in the MOCS1 gene leads to complete missplicing of an alternatively spliced exon in a patient with molybdenum cofactor deficiency. J Inherit Metab Dis 32:560569.
  • Arnold GL, Greene CL, Stout JP, Goodman SI. 1993. Molybdenum cofactor deficiency. J Pediatr 123:595598.
  • Bamforth FJ, Johnson JL, Davidson AG, Wong LT, Lockitch G, Applegarth DA. 1990. Biochemical investigation of a child with molybdenum cofactor deficiency. Clin Biochem 23:537542.
  • Bell P, Moscioni AD, McCarter RJ, Wu D, Gao G, Hoang A, Sanmiguel JC, Sun X, Wivel NA, Raper SE, Furth EE, Batshaw ML, Wilson JM. 2006. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol Ther 14:3444.
  • Carragher FM, Kirk JM, Steer C, Allen J, Dorche C. 1999. False negative thiosulphate screening test in a case of molybdenum cofactor deficiency. J Inherit Metab Dis 22:842843.
  • Clarke NJ, Laurie SH. 1980. The copper–molybdenum antagonism in ruminants. I. The formation of thiomolybdates in animal rumen. J Inorg Biochem 12:3743.
  • Coskun T, Yetuk M, Yurdakok M, Tekinalp G. 1998. Blood uric acid as a pointer to the diagnosis of molybdenum cofactor deficiency. Acta Paediatr 87:714715.
  • Donsante A, Vogler C, Muzyczka N, Crawford JM, Barker J, Flotte T, Campbell-Thompson M, Daly T, Sands MS. 2001. Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors. Gene Ther 8:13431346.
  • Duran M, Beemer FA, van de Heiden C, Korteland J, de Bree PK, Brink M, Wadman SK, Lombeck I. 1978. Combined deficiency of xanthine oxidase and sulphite oxidase: a defect of molybdenum metabolism or transport? J Inherit Metab Dis 1:175178.
  • Endres W, Shin YS, Gunther R, Ibel H, Duran M, Wadman SK. 1988. Report on a new patient with combined deficiencies of sulphite oxidase and xanthine dehydrogenase due to molybdenum cofactor deficiency. Eur J Pediatr 148:246249.
  • Feng G, Tintrup H, Kirsch J, Nichol MC, Kuhse J, Betz H, Sanes JR. 1998. Dual requirement for gephyrin in glycine receptor clustering and molybdoenzyme activity. Science 282:13211324.
  • Gray TA, Nicholls RD. 2000. Diverse splicing mechanisms fuse the evolutionarily conserved bicistronic MOCS1A and MOCS1B open reading frames. RNA 6:928936.
  • Gross-Hardt S, Reiss J. 2002. The bicistronic MOCS1 gene has alternative start codons on two mutually exclusive exons. Mol Genet Metab 76:340343.
  • Gumus H, Ghesquiere S, Per H, Kondolot M, Ichida K, Poyrazoglu G, Kumandas S, Engelen J, Dundar M, Caglayan AO. 2010. Maternal uniparental isodisomy is responsible for serious molybdenum cofactor deficiency. Dev Med Child Neurol 52:868872.
  • Hahnewald R, Leimkuhler S, Vilaseca A, Acquaviva-Bourdain C, Lenz U, Reiss J. 2006. A novel MOCS2 mutation reveals coordinated expression of the small and large subunit of molybdopterin synthase. Mol Genet Metab 89:210213.
  • Hahnewald R, Wegner W, Reiss J. 2009. AAV-mediated gene therapy for metabolic diseases: dosage and reapplication studies in the molybdenum cofactor deficiency model. Genet Vaccines Ther 7:9.
  • Hanzelmann P, Hernandez HL, Menzel C, Garcia-Serres R, Huynh BH, Johnson MK, Mendel RR, Schindelin H. 2004. Characterization of MOCS1A, an oxygen-sensitive iron–sulfur protein involved in human molybdenum cofactor biosynthesis. J Biol Chem 279:3472134732.
  • Hanzelmann P, Schwarz G, Mendel RR. 2002. Functionality of alternative splice forms of the first enzymes involved in human molybdenum cofactor biosynthesis. J Biol Chem 277:1830318312.
  • Havemeyer A, Bittner F, Wollers S, Mendel R, Kunze T, Clement B. 2006. Identification of the missing component in the mitochondrial benzamidoxime prodrug-converting system as a novel molybdenum enzyme. J Biol Chem 281:3479634802.
  • Hughes EF, Fairbanks L, Simmonds HA, Robinson RO. 1998. Molybdenum cofactor deficiency-phenotypic variability in a family with a late-onset variant. Dev Med Child Neurol 40:5761.
  • Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O. 1997. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J Clin Invest 99:23912397.
  • Ichida K, Aydin HI, Hosoyamada M, Kalkanoglu HS, Dursun A, Ohno I, Coskun T, Tokatli A, Shibasaki T, Hosoya T. 2006. A Turkish case with molybdenum cofactor deficiency. Nucleosides Nucleotides Nucleic Acids 25:10871091.
  • Ichida K, Matsumura T, Sakuma R, Hosoya T, Nishino T. 2001. Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II. Biochem Biophys Res Commun 282:11941200.
  • Johnson JL. 2003. Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. Prenat Diagn 23:68.
  • Johnson JL, Coyne KE, Rajagopalan KV, Van Hove JL, Mackay M, Pitt J, Boneh A. 2001. Molybdopterin synthase mutations in a mild case of molybdenum cofactor deficiency. Am J Med Genet 104:169173.
  • Johnson JL, Rajagopalan KV, Lanman JT, Schutgens RB, van Gennip AH, Sorensen P, Applegarth DA. 1991. Prenatal diagnosis of molybdenum cofactor deficiency by assay of sulphite oxidase activity in chorionic villus samples. J Inherit Metab Dis 14:932937.
  • Johnson JL, Wadman SK. 1989. Molybdenum cofactor deficiency. In: ScriverCR, BeaudetAL, SlyWS, ValleD, editors. The metabolic basis of inherited disease. New York: McGraw-Hill. p 14631475.
  • Johnson JL, Waud WR, Rajagopalan KV, Duran M, Beemer FA, Wadman SK. 1980. Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. Proc Natl Acad Sci USA 77:37153719.
  • Johnson JL, Wuebbens MM, Mandell R, Shih VE. 1989. Molybdenum cofactor biosynthesis in humans. Identification of two complementation groups of cofactor-deficient patients and preliminary characterization of a diffusible molybdopterin precursor. J Clin Invest 83:897903.
  • Kamdar KP, Shelton ME, Finnerty V. 1994. The Drosophila molybdenum cofactor gene cinnamon is homologous to three Escherichia coli cofactor proteins and to the rat protein gephyrin. Genetics 137:791801.
  • Kavukcu S, Soylu A, Sahin B, Turkmen M, Aydin A, Dirik E. 2000. Clinical quiz. Molybdenum cofactor deficiency. Pediatr Nephrol 14:11451147.
  • Kirsch J, Wolters I, Triller A, Betz H. 1993. Gephyrin antisense oligonucleotides prevent glycine receptor clustering in spinal neurons. Nature 366:745748.
  • Kozak M. 1978. How do eucaryotic ribosomes select initiation regions in messenger RNA? Cell 15:11091123.
  • Kugler S, Hahnewald R, Garrido M, Reiss J. 2007. Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency. Am J Hum Genet 80:291297.
  • Kuper J, Llamas A, Hecht HJ, Mendel RR, Schwarz G. 2004. Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism. Nature 430:803806.
  • Lee HJ, Adham IM, Schwarz G, Kneussel M, Sass JO, Engel W, Reiss J. 2002. Molybdenum cofactor-deficient mice resemble the phenotype of human patients. Hum Mol Genet 11:33093317.
  • Leimkuhler S, Charcosset M, Latour P, Dorche C, Kleppe S, Scaglia F, Szymczak I, Schupp P, Hahnewald R, Reiss J. 2005. Ten novel mutations in the molybdenum cofactor genes MOCS1 and MOCS2 and in vitro characterization of a MOCS2 mutation that abolishes the binding ability of molybdopterin synthase. Hum Genet 117:565570.
  • Llamas A, Otte T, Multhaup G, Mendel RR, Schwarz G. 2006. The Mechanism of nucleotide-assisted molybdenum insertion into molybdopterin. A novel route toward metal cofactor assembly. J Biol Chem 281:1834318350.
  • Macaya A, Brunso L, Fernandez-Castillo N, Arranz JA, Ginjaar HB, Cuenca-Leon E, Corominas R, Roig M, Cormand B. 2005. Molybdenum cofactor deficiency presenting as neonatal hyperekplexia: a clinical, biochemical and genetic study. Neuropediatrics 36:389394.
  • Matthies A, Rajagopalan KV, Mendel RR, Leimkuhler S. 2004. Evidence for the physiological role of a rhodanese-like protein for the biosynthesis of the molybdenum cofactor in humans. Proc Natl Acad Sci USA 101:59465951.
  • Mize C, Johnson JL, Rajagopalan KV. 1995. Defective molybdopterin biosynthesis: clinical heterogeneity associated with molybdenum cofactor deficiency. J Inherit Metab Dis 18:283290.
  • Ngu LH, Afroze B, Chen BC, Affandi O, Zabedah MY. 2009. Molybdenum cofactor deficiency in a Malaysian child. Singapore Med J 50:e365e367.
  • Novotny JA, Turnlund JR. 2007. Molybdenum intake influences molybdenum kinetics in men. J Nutr 137:3742.
  • Parini R, Briscioli V, Caruso U, Dorche C, Fortuna R, Minniti G, Selicorni A, Vismara E, Mancini G. 1997. Spherophakia associated with molybdenum cofactor deficiency. Am J Med Genet 73:272275.
  • Pateman JA, Cove DJ, Rever BM, Roberts DB. 1964. A common co-factor for nitrate reductase and xanthine dehydrogenase which also regulates the synthesis of nitrate reductase. Nature 201:5860.
  • Per H, Gumus H, Ichida K, Caglayan O, Kumandas S. 2007. Molybdenum cofactor deficiency: clinical features in a Turkish patient. Brain Dev 29:365368.
  • Pintos-Morell G, Naranjo MA, Artigas M, Roge M, Rodes M, Coll MJ, Johnson JL, Rajagopalan KV. 1995. Molybdenum cofactor deficiency associated with Dandy-Walker malformation. J Inherit Metab Dis 18:8687.
  • Prior P, Schmitt B, Grenningloh G, Pribilla I, Multhaup G, Beyreuther K, Maulet Y, Werner P, Langosch D, Kirsch J, and others. 1992. Primary structure and alternative splice variants of gephyrin, a putative glycine receptor-tubulin linker protein. Neuron 8:11611170.
  • Rajagopalan KV. 1988. Molybdenum: an essential trace element in human nutrition. Annu Rev Nutr 8:401427.
  • Rajagopalan KV, Johnson JL. 1992. The pterin molybdenum cofactors. J Biol Chem 267:1019910202.
  • Reiss J. 2000. Genetics of molybdenum cofactor deficiency. Hum Genet 106:157163.
  • Reiss J, Bonin M, Schwegler H, Sass JO, Garattini E, Wagner S, Lee HJ, Engel W, Riess O, Schwarz G. 2005. The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis. Mol Genet Metab 85:1220.
  • Reiss J, Christensen E, Dorche C. 1999a. Molybdenum cofactor deficiency: first prenatal genetic analysis. Prenat Diagn 19:386388.
  • Reiss J, Christensen E, Kurlemann G, Zabot MT, Dorche C. 1998a. Genomic structure and mutational spectrum of the bicistronic MOCS1 gene defective in molybdenum cofactor deficiency type A. Hum Genet 103:639644.
  • Reiss J, Cohen N, Dorche C, Mandel H, Mendel RR, Stallmeyer B, Zabot MT, Dierks T. 1998b. Mutations in a polycistronic nuclear gene associated with molybdenum cofactor deficiency. Nat Genet 20:5153.
  • Reiss J, Dorche C, Stallmeyer B, Mendel RR, Cohen N, Zabot MT. 1999b. Human molybdopterin synthase gene: genomic structure and mutations in molybdenum cofactor deficiency type B. Am J Hum Genet 64:706711.
  • Reiss J, Gross-Hardt S, Christensen E, Schmidt P, Mendel RR, Schwarz G. 2001. A mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency. Am J Hum Genet 68:208213.
  • Reiss J, Johnson JL. 2003. Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Hum Mutat 21:569576.
  • Salman MS, Ackerley C, Senger C, Becker L. 2002. New insights into the neuropathogenesis of molybdenum cofactor deficiency. Can J Neurol Sci 29:9196.
  • Salvan AM, Chabrol B, Lamoureux S, Confort-Gouny S, Cozzone PJ, Vion-Dury J. 1999. In vivo brain proton MR spectroscopy in a case of molybdenum cofactor deficiency. Pediatr Radiol 29:846848.
  • Sass JO, Gunduz A, Araujo Rodrigues Funayama C, Korkmaz B, Dantas Pinto KG, Tuysuz B, Yanasse Dos Santos L, Taskiran E, de Fatima Turcato M, Lam CW, Reiss J, Walter M, Yalcinkaya C, Camelo Jr JS. 2010. Functional deficiencies of sulfite oxidase: Differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia. Brain Dev 32:544549.
  • Sass JO, Kishikawa M, Puttinger R, Reiss J, Erwa W, Shimizu A, Sperl W. 2003. Hypohomocysteinaemia and highly increased proportion of S-sulfonated plasma transthyretin in molybdenum cofactor deficiency. J Inherit Metab Dis 26:8082.
  • Schuierer G, Kurlemann G, Bick U, Stephani U. 1995. Molybdenum-cofactor deficiency: CT and MR findings. Neuropediatrics 26:5154.
  • Schwarz G, Santamaria-Araujo JA, Wolf S, Lee HJ, Adham IM, Grone HJ, Schwegler H, Sass JO, Otte T, Hanzelmann P, Mendel RR, Engel W, Reiss J. 2004. Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli. Hum Mol Genet 13:12491255.
  • Serrano M, Lizarraga I, Reiss J, Dias AP, Perez-Duenas B, Vilaseca MA, Artuch R, Campistol J, Garcia-Cazorla A. 2007. Cranial ultrasound and chronological changes in molybdenum cofactor deficiency. Pediatr Radiol 37:10431046.
  • Shalata A, Mandel H, Dorche C, Zabot MT, Shalev S, Hugeirat Y, Arieh D, Ronit Z, Reiss J, Anbinder Y, Cohen N. 2000. Prenatal diagnosis and carrier detection for molybdenum cofactor deficiency type A in northern Israel using polymorphic DNA markers. Prenat Diagn 20:711.
  • Shanmugam KT, Stewart V, Gunsalus RP, Boxer DH, Cole JA, Chippaux M, DeMoss JA, Giordano G, Lin EC, Rajagopalan KV. 1992. Proposed nomenclature for the genes involved in molybdenum metabolism in Escherichia coli and Salmonella typhimurium. Mol Microbiol 6:34523454.
  • Slot HM, Overweg-Plandsoen WC, Bakker HD, Abeling NG, Tamminga P, Barth PG, Van Gennip AH. 1993. Molybdenum-cofactor deficiency: an easily missed cause of neonatal convulsions. Neuropediatrics 24:139142.
  • Stallmeyer B, Drugeon G, Reiss J, Haenni AL, Mendel RR. 1999a. Human molybdopterin synthase gene: identification of a bicistronic transcript with overlapping reading frames. Am J Hum Genet 64:698705.
  • Stallmeyer B, Nerlich A, Schiemann J, Brinkmann H, Mendel RR. 1995. Molybdenum co-factor biosynthesis: the Arabidopsis thaliana cDNA cnx1 encodes a multifunctional two-domain protein homologous to a mammalian neuroprotein, the insect protein Cinnamon and three Escherichia coli proteins. Plant J 8:751762.
  • Stallmeyer B, Schwarz G, Schulze J, Nerlich A, Reiss J, Kirsch J, Mendel RR. 1999b. The neurotransmitter receptor-anchoring protein gephyrin reconstitutes molybdenum cofactor biosynthesis in bacteria, plants, and mammalian cells. Proc Natl Acad Sci USA 96:13331338.
  • Tan WH, Eichler FS, Hoda S, Lee MS, Baris H, Hanley CA, Grant PE, Krishnamoorthy KS, Shih VE. 2005. Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. Pediatrics 116:757766.
  • Teksam O, Yurdakok M, Coskun T. 2005. Molybdenum cofactor deficiency presenting with severe metabolic acidosis and intracranial hemorrhage. J Child Neurol 20:155157.
  • Teschner J, Lachmann N, Schulze J, Geisler M, Selbach K, Santamaria-Araujo J, Balk J, Mendel RR, Bittner F. 2010. A novel role for Arabidopsis mitochondrial ABC transporter ATM3 in molybdenum cofactor biosynthesis. Plant Cell 22:468480.
  • Topcu M, Coskun T, Haliloglu G, Saatci I. 2001. Molybdenum cofactor deficiency: report of three cases presenting as hypoxic–ischemic encephalopathy. J Child Neurol 16:264270.
  • Unkles SE, Heck IS, Appleyard MV, Kinghorn JR. 1999. Eukaryotic molybdopterin synthase. Biochemical and molecular studies of Aspergillus nidulans cnxG and cnxH mutants. J Biol Chem 274:1928619293.
  • van Gennip AH, Abeling NG, Stroomer AE, Overmars H, Bakker HD. 1994. The detection of molybdenum cofactor deficiency: clinical symptomatology and urinary metabolite profile. J Inherit Metab Dis 17:142145.
  • Veldman A, Santamaria-Araujo JA, Sollazzo S, Pitt J, Gianello R, Yaplito-Lee J, Wong F, Ramsden CA, Reiss J, Cook I, Fairweather J, Schwarz G. 2010. Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 125:e1249e1254.
  • Zhang X, Vincent AS, Halliwell B, Wong KP. 2004. A mechanism of sulfite neurotoxicity: direct inhibition of glutamate dehydrogenase. J Biol Chem 279:4303543045.